Glucagon-like Receptor-1 Agonist for Obesity: Weight Loss Outcomes, Tolerability, Side Effects, and Risks
Brightens your skin tone, and fades dark spots, pigmentation and melasma
If you experience any adverse reactions, such as nasal irritation, runny nose, or headaches, discontinue use and consult with a healthcare provider
Were now looking forward to the FDA approving the GLP-1 class of drugs for more heart-related reasons
When a Switch to Tirzepatide Makes Clinical Sense Patients should consider switching to tirzepatide if they've reached a weight loss plateau on semaglutide, are not meeting their health goals, or have been on semaglutide for 6+ months without desired progress
Petersen AM, Krogfelt KA